Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tod W Speer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Proapoptotic receptor agonists, targeted radionuclide therapy, and the treatment of central nervous system malignancies: in regard to Fiveash et Al. (Int J Radiat Oncol Biol Phys 2008;71:507-516)Tod W Speer
Blood|September 10, 2008
Fully human monoclonal antibodies and targeted radionuclide therapyTod W Speer
Clinical Advances in Hematology & Oncology : H&O|June 6, 2008
Will radioimmunotherapy survive?Tod W Speer, James S Welsh
Case Reports in Oncology|November 28, 2012
Successful treatment of an angiosarcoma of the nose with radiation therapyVatsal B Patel, Tod W Speer
Cancer|July 13, 2002
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or bothJames T Parsons, William M Mendenhall, Scott P Stringer, et al.
American Journal of Clinical Oncology|June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Proapoptotic receptor agonists, targeted radionuclide therapy, and the treatment of central nervous system malignancies: in regard to Fiveash et Al. (Int J Radiat Oncol Biol Phys 2008;71:507-516)Tod W Speer
Blood|September 10, 2008
Fully human monoclonal antibodies and targeted radionuclide therapyTod W Speer
Clinical Advances in Hematology & Oncology : H&O|June 6, 2008
Will radioimmunotherapy survive?Tod W Speer, James S Welsh
Case Reports in Oncology|November 28, 2012
Successful treatment of an angiosarcoma of the nose with radiation therapyVatsal B Patel, Tod W Speer
Cancer|July 13, 2002
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or bothJames T Parsons, William M Mendenhall, Scott P Stringer, et al.
American Journal of Clinical Oncology|June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
Pageof 1